Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02660632
Other study ID # R / 15.12.48
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2017
Est. completion date May 2018

Study information

Verified date June 2018
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pulmonary complications are among the most important postoperative complications after midline incisions, for which different analgesic modalities have been tried.

Epidural analgesia is the recommended technique to relieve pain after major abdominal surgery owing to the proved superior analgesia, reduction of opioid related side effects as nausea, vomiting, pruritis and sedation, earlier recovery of bowel function and earlier ability for postoperative mobility However, it is not without complications.

Rectus sheath block provides several advantages over epidural anesthesia. It lessens the potential risks associated with neuraxial techniques, so it may represent a novel alternative approach for somatic analgesia after major abdominal surgeries. Although patients with rectus sheath block may experience some visceral pain, it is usually minimal by 24 hours after surgery.


Description:

The aim of this study is to compare the effects of thoracic epidural analgesia and rectus sheath blockade on postoperative pulmonary functions, pain scores, duration of analgesia, sedation scores, patients' satisfaction and adverse effects.

FEV1, FEV1/FVC ratio will be measured by a bed side spirometer.

- Induction of anesthesia: propofol 1.5-2.5 mg kg-1.

- Muscle Relaxants: rocuronium 0.6 mg kg-1 for induction.

- Maintenance: Sevoflurane 0.7-1.5 MAC vaporized in air-oxygen (40% inspired fraction).

Radial artery catheterization: under complete aseptic conditions 20G cannula will be inserted into the radial artery of non-dominant hand after performing modified Allen`s test and local infiltration of 0.5ml xylocaine 2% .

Thoracic epidural catheter will be inserted before induction of general anaesthesia under aseptic insertion conditions and using loss of resistance to air technique with the patient in the sitting position at T9- T11 interspaces.

The Rectus sheath catheters will be inserted bilaterally using ultrasound (SonoSite M-Turbo®, Sonosite , USA) guidance as described by Webster after induction of general anaesthesia.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date May 2018
Est. primary completion date May 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiologists physical class I to III.

- Patients scheduled for elective midline laparotomy.

Exclusion Criteria:

- Morbid obese patients.

- Severe or uncompensated cardiovascular disease.

- Significant renal disease.

- Significant hepatic disease.

- Pregnancy.

- Lactating.

- Allergy to the study medications.

- Psychological disorder.

- Neurological disorder.

- Communication barrier.

- Mental disorders.

- Epilepsy.

- FEV1 or FEV1/FVC ratio less than 50%, dyspnea with a New York Heart Association class IV.

- Drug or alcohol abuse.

- Contraindications to epidural anaesthesia.

- Opioid analgesic medication within 24 h before the operation.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Thoracic epidural analgesia (TEA)
Epidural catheter will be inserted at T9-T11. Then, epidural analgesia will be activated with administering bolus of 10 mls 0.25% bupivacaine in conjunction with100 mcg fentanyl to establish a block. This will be followed by an infusion of 0.125% bupivacaine in conjunction with 2 mcg/ ml fentanyl at a rate of 10 mls /hour and then titrated to effect for up to 48 hour postoperative
Rectus sheath catheter block
Following insertion of bilateral rectus sheath catheters, 20 ml of 0.25% bupivacaine will be injected through each one. Then continuous infusion pumps will be connected to the catheters and set to deliver boluses of 20 mL of 0.25% bupivacaine, with a 4-hour lockout for up to 48 h postoperatively.

Locations

Country Name City State
Egypt Mansoura university Mansourah DK

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in forced expiratory volume in 1 second (FEV1) Before and for 72 hours after surgery
Primary Changes in ratio between forced expiratory volume in 1 s and forced vital capacity (FEV1/FVC) Before and for 72 hours after surgery
Secondary Changes in arterial blood gases Before and for 72 hours after surgery
Secondary Visual analog pain scores Postoperative pain will be assessed on rest and with cough and during movements for both of visceral and parietal pain for 48 hours after surgery
Secondary Sedation score Sedation scores using a sedation scale (awake and alert= 0; quietly awake= 1; asleep but easily roused= 2; deep sleep= 3. for 48 hours after surgery
Secondary Postoperative nausea and vomiting The degree of nausea and vomiting. Nausea will be measured using a numerical rating system (none= 0; mild= 1; moderate= 2; severe= 3). The number of vomiting episodes and the number of anti-emetics received for 48 hours after surgery
Secondary Return of bowel function The times to first flatus, defecation, intake of clear liquid and solid food tolerance for 72 hours after surgery
Secondary Time to hospital discharge from the end of anesthesia for 15 days after surgery
Secondary Cumulative tramadol use For 48 hours after surgery
Secondary Overall patient's satisfaction Patient overall satisfaction will be assessed before hospital discharge using the visual analog score For 48 hours after surgery
Secondary Intraoperative use of ephedrine For 5 hours after induction of anesthesia
Secondary Postoperative cardio-respiratory complications For 7 days after surgery
Secondary Postoperative wound infection For 21 days after surgery
See also
  Status Clinical Trial Phase
Completed NCT04691531 - Decreasing the Invasiveness of Ultrasound Guided Caudal Block: A Comparison Between 22-gauge and 27-guage Needles N/A
Completed NCT00564603 - Continuous Infusion of Dexamethasone Plus Tramadol Adjunct to Morphine PCA After Abdominal Hysterectomy Phase 4